600276 恒瑞医药
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额4,585,4467,643,6651,265,2654,218,8163,431,935
投资活动产生之现金流量净额(1,873,446)1,222,315390,289(546,263)1,797,829
筹资活动产生之现金流量净额(1,506,524)(3,144,426)(318,770)(998,322)291,188
汇率变动对现金及现金等价物的影响(21,220)12,53380,497(16,866)(89,079)
现金及现金等价物净增加/(减少)1,184,2565,734,0871,417,2812,657,3655,431,873
期初现金及现金等价物余额20,271,52414,537,43713,120,15610,462,7915,030,918
期末现金及现金等价物余额21,455,78020,271,52414,537,43713,120,15610,462,791